Stryker Corporation (SYK)
$282.60+1.90%Close
SELLRECOVERY · day 10
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $108.3B
- Beta
- 0.77
- Div yield
- 1.27%
- P/E (TTM)
- 28.62
- Short % float
- 1.65%
- Days to cover
- 2.0
- SI change
- -25.2%
- 1W
- -0.92%
- 1M
- +2.88%
- vs SPY 1W
- -1.34%
- vs SPY 1M
- +0.82%
Industry peers
FMP comparable companies · ranked by market cap
- MDTSELLMedtronic Plc$117.7BRECOVERYQ 14$91.93+3.90%
- ZBHSELLZimmer Biomet Holdings, Inc.$17.8BBEARQ 9$92.17+3.40%
- SNNSELLSmith & Nephew plc$11.6BRECOVERYQ 15$27.67+1.58%
- GMEDSELLGlobus Medical, Inc.$10.3BRECOVERYQ 22$76.24+2.13%
- ATECBUYAlphatec Holdings, Inc.$1.7BRECOVERYQ -0$11.25+5.44%
- CNMDSELLCONMED Corporation$1.4BRECOVERYQ 13$45.36+2.12%
- IARTSELLIntegra LifeSciences Holdings Corporation$1.1BCRISISQ 9$13.98+4.02%
- ENOVSELLEnovis Corporation$1.1BRECOVERYQ 0$18.25+3.17%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on SYK?
- LOPJLB’s latest quantitative signal on Stryker Corporation (SYK) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is SYK in?
- Stryker Corporation (SYK) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Stryker Corporation (SYK) do?
- Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant produ…